Administration
Administration
批准号:
8237139
负责人:
MATTHEW L. MEYERSON
金额:
$16.98万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-05-11 至 2017-04-30
关键词:
Advisory CommitteesAreaBackBudgetsClinicClinicalCollaborationsCommunicationCommunitiesComplexConsultationsDana-Farber Cancer InstituteDataData DisplayDevelopmentDiagnosticEnsureEnzymatic BiochemistryEvaluation ResearchEventEvolutionFosteringFundingGenomicsGoalsGrantGroup MeetingsInstructionInternetLaboratoriesLeadLungMalignant neoplasm of lungManuscriptsMethodsMonitorNon-Small-Cell Lung CarcinomaOnline SystemsPatientsPerformancePreparationProtein KinasePublicationsRecommendationResearchResearch PersonnelResearch Project GrantsResource SharingScientistServicesSuggestionSynthesis ChemistryTestingTherapeuticTranslatingTranslationscancer therapydata sharingeditorialinnovationkinase inhibitormeetingsmemberprogramsprotein structureresearch studytherapeutic targettool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY (See instructions):
The purpose of the Administrative Core is to provide support for the integrated Program on Lung Cancer
Targeted Therapies, whose ultimate goal is to translate genomic events into the therapy of patients with nonsmall
cell lung cancer (NSCLC) by discovery, testing, and validating kinase inhibitors as targeted therapies
for genomically selected NSCLC . Specifically, the Core Director and Co-Director will provide guidance and
oversight to the Projects and shared research Cores and will lead the evaluation of research progress
including consultation with an Internal Advisory Committee and an External Advisory Board. The
Administrative Core of this Program Project application is to coordinate these interrelated complementary
research projects to maximize their scientific synergy and to share the findings with the scientific community.
The Core Directors will co-ordinate staff assistance to projects including administrative support to facilitate
scientific progress including meeting arrangements, editorial services for manuscript preparation, and web
development services for internal and external communications.
The specific aims of the Administrative Core are summarized below.
Specific Aim 1: Monitor projects and shared resource cores and to evaluate overall research progress.
Specific Aim 2: Foster collaboration and communication among the projects and shared resource cores.
Specific Aim 3; Provide fiscal oversight and support for the program.
Specific Aim 4: Promote the clinical translation of diagnostic and therapeutic discoveries from the program.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Lung Adenocarcinoma: From Genome Alterations to Therapeutic Discovery
-
批准号:10299281
-
项目类别:
-
资助金额:$106.8万
-
财政年份:2015
-
负责人:MATTHEW L. MEYERSON
-
依托单位:
How do genome alterations cause human lung cancer?
-
批准号:8955791
-
项目类别:
-
资助金额:$102.56万
-
财政年份:2015
-
负责人:MATTHEW L. MEYERSON
-
依托单位:
NKX2-1 Enhancer Amplification and Lineage Addiction in Lung Adenocarcinoma
-
批准号:10598959
-
项目类别:
-
资助金额:$9.41万
-
财政年份:2015
-
负责人:MATTHEW L. MEYERSON
-
依托单位:
Lung Adenocarcinoma: From Genome Alterations to Therapeutic Discovery
-
批准号:10455040
-
项目类别:
-
资助金额:$102.37万
-
财政年份:2015
-
负责人:MATTHEW L. MEYERSON
-
依托单位:
How do genome alterations cause human lung cancer?
-
批准号:9118129
-
项目类别:
-
资助金额:$102.75万
-
财政年份:2015
-
负责人:MATTHEW L. MEYERSON
-
依托单位:
Lung Adenocarcinoma: From Genome Alterations to Therapeutic Discovery
-
批准号:10683176
-
项目类别:
-
资助金额:$102.37万
-
财政年份:2015
-
负责人:MATTHEW L. MEYERSON
-
依托单位:
Protein Kinase Therapeutic Targets for Non-Small Cell Lung Carcinoma
-
批准号:8490596
-
项目类别:
-
资助金额:$150.64万
-
财政年份:2012
-
负责人:MATTHEW L. MEYERSON
-
依托单位:
Protein Kinase Therapeutic Targets for Non-Small Cell Lung Carcinoma
-
批准号:8660037
-
项目类别:
-
资助金额:$169.53万
-
财政年份:2012
-
负责人:MATTHEW L. MEYERSON
-
依托单位:
Protein Kinase Therapeutic Targets for Non-Small Cell Lung Carcinoma
-
批准号:8844212
-
项目类别:
-
资助金额:$174.77万
-
财政年份:2012
-
负责人:MATTHEW L. MEYERSON
-
依托单位:
Project 3: Targeting transcriptional mechanisms of therapeutic resistance in non-small cell lung cancer.
-
批准号:10231100
-
项目类别:
-
资助金额:$34.82万
-
财政年份:2012
-
负责人:MATTHEW L. MEYERSON
-
依托单位:
Core D: Program Administration
-
批准号:10231105
-
项目类别:
-
资助金额:$12.66万
-
财政年份:2012
-
负责人:MATTHEW L. MEYERSON
-
依托单位:
Protein Kinase Therapeutic Targets for Non-Small Cell Lung Carcinoma
-
批准号:9766077
-
项目类别:
-
资助金额:$184.71万
-
财政年份:2012
-
负责人:MATTHEW L. MEYERSON
-
依托单位:
Protein Kinase Therapeutic Targets for Non-Small Cell Lung Carcinoma
-
批准号:10231097
-
项目类别:
-
资助金额:$184.62万
-
财政年份:2012
-
负责人:MATTHEW L. MEYERSON
-
依托单位:
DDR2 kinase inhibition in squamous cell lung carcinomas
-
批准号:8237129
-
项目类别:
-
资助金额:$42.66万
-
财政年份:2012
-
负责人:MATTHEW L. MEYERSON
-
依托单位:
Protein Kinase Therapeutic Targets for Non-Small Cell Lung Carcinoma
-
批准号:8216244
-
项目类别:
-
资助金额:$188.44万
-
财政年份:2012
-
负责人:MATTHEW L. MEYERSON
-
依托单位:
Center for Cancer Genome Characterization
-
批准号:7911111
-
项目类别:
-
资助金额:$61.13万
-
财政年份:2009
-
负责人:MATTHEW L. MEYERSON
-
依托单位:
An infrastructure for cancer virus discovery from next-generation sequencing data
-
批准号:7856252
-
项目类别:
-
资助金额:$76.51万
-
财政年份:2009
-
负责人:MATTHEW L. MEYERSON
-
依托单位:
An infrastructure for cancer virus discovery from next-generation sequencing data
-
批准号:7941869
-
项目类别:
-
资助金额:$78.64万
-
财政年份:2009
-
负责人:MATTHEW L. MEYERSON
-
依托单位:
Inhibitor-sensitive and -resistant EGFR mutants from lung cancer and glioblastoma
-
批准号:7213358
-
项目类别:
-
资助金额:$32.57万
-
财政年份:2006
-
负责人:MATTHEW L. MEYERSON
-
依托单位:
Center for Cancer Genome Characterization
-
批准号:7233746
-
项目类别:
-
资助金额:$238.78万
-
财政年份:2006
-
负责人:MATTHEW L. MEYERSON
-
依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
-
批准号:2021JJ40433
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:孙磊
-
依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
-
批准号:32001603
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:段真珍
-
依托单位:
AREA国际经济模型的移植.改进和应用
-
批准号:18870435
-
项目类别:面上项目
-
资助金额:2.0万元
-
批准年份:1988
-
负责人:史树中
-
依托单位: